Yayın: Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
| dc.contributor.author | ALTINTOP, MEHLİKA DİLEK | |
| dc.contributor.author | CANTÜRK, ZERRİN | |
| dc.contributor.author | ÖZDEMİR, AHMET | |
| dc.contributor.orcid | 0000-0002-8159-663X | |
| dc.contributor.orcid | 0000-0001-7709-4285 | |
| dc.contributor.orcid | 0000-0003-0280-5550 | |
| dc.date.accessioned | 2025-11-13T09:52:09Z | |
| dc.date.issued | 2023-10-30 | |
| dc.identifier.doi | https://doi.org/10.1021/acsomega.3c05860 | |
| dc.identifier.endpage | 42877 | |
| dc.identifier.issn | 2470-1343 | |
| dc.identifier.issue | 45 | |
| dc.identifier.openalex | W4388103727 | |
| dc.identifier.startpage | 42867 | |
| dc.identifier.uri | https://hdl.handle.net/11421/2437 | |
| dc.identifier.uri | https://doi.org/10.1021/acsomega.3c05860 | |
| dc.identifier.volume | 8 | |
| dc.language.iso | en | |
| dc.relation.ispartof | ACS Omega | |
| dc.rights | openAccess | |
| dc.subject | K562 cells | |
| dc.subject | Myeloid leukemia | |
| dc.subject | Cytotoxicity | |
| dc.subject | Leukemia | |
| dc.subject | Acute promyelocytic leukemia | |
| dc.subject | Chemistry | |
| dc.subject | Apoptosis | |
| dc.subject | Cytotoxic T cell | |
| dc.subject | Bortezomib | |
| dc.subject | Pharmacology | |
| dc.subject | In vitro | |
| dc.subject | IC50 | |
| dc.subject | THP1 cell line | |
| dc.subject | Cell culture | |
| dc.subject | Cancer research | |
| dc.subject | Medicine | |
| dc.subject | Immunology | |
| dc.subject | Biology | |
| dc.subject | Biochemistry | |
| dc.subject | Retinoic acid | |
| dc.subject | Multiple myeloma | |
| dc.title | Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5048968214 | |
| local.authorid.openalex | A5085224535 | |
| local.authorid.openalex | A5100651829 |
